GSK PLC SP. ADR/2 NEW (GS70) — Net Asset Momentum
GSK PLC SP. ADR/2 NEW (GS70) recorded a net asset momentum of 21.9% as of December 2025, with net assets of €15.96 Billion EUR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See operational self-sufficiency of GSK PLC SP. ADR/2 NEW to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
GSK PLC SP. ADR/2 NEW Net Asset Momentum (2021–2025)
This chart tracks GSK PLC SP. ADR/2 NEW's year-over-year net asset growth across 5 annual reporting periods from 2021 to 2025. The most recent momentum reading is +21.9%, with net assets of €15.96 Billion EUR as of December 2025. Read GSK PLC SP. ADR/2 NEW (GS70) financial obligations for a breakdown of total debt and financial obligations.
Annual Net Asset History for GSK PLC SP. ADR/2 NEW (2021–2025)
The table below shows the complete annual net asset history for GSK PLC SP. ADR/2 NEW from 2021 to 2025, covering 5 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see market cap of GSK PLC SP. ADR/2 NEW.
| Year | Net Assets (EUR) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | €15.96 Billion | €61.12 Billion | €45.16 Billion | ▲ +21.9% |
| 2024 | €13.09 Billion | €59.46 Billion | €46.38 Billion | ▲ +2.3% |
| 2023 | €12.79 Billion | €59.01 Billion | €46.21 Billion | ▲ +26.7% |
| 2022 | €10.10 Billion | €60.15 Billion | €50.05 Billion | ▼ -52.7% |
| 2021 | €21.34 Billion | €79.10 Billion | €57.76 Billion | — |